Variant report
Variant | nsv513296 |
---|---|
Chromosome Location | chr6:5896617-5900093 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536929910 | chr6:5896625-5896626 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs539681697 | chr6:5896693-5896694 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557772777 | chr6:5896751-5896752 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566633454 | chr6:5896777-5896778 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs12191239 | chr6:5896793-5896794 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs184086705 | chr6:5896835-5896836 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558158967 | chr6:5896837-5896838 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114807641 | chr6:5896851-5896852 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs139437202 | chr6:5896855-5896856 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577967190 | chr6:5896890-5896891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12191308 | chr6:5896899-5896900 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs187448822 | chr6:5896927-5896928 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs527850179 | chr6:5896949-5896950 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs543226445 | chr6:5896950-5896951 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs67962142 | chr6:5896982-5896983 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs80291928 | chr6:5897004-5897005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12211137 | chr6:5897007-5897008 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs192299368 | chr6:5897013-5897014 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550707241 | chr6:5897014-5897015 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568791376 | chr6:5897033-5897034 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563405276 | chr6:5897034-5897035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532813524 | chr6:5897064-5897065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs74551875 | chr6:5897065-5897066 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs9504571 | chr6:5897082-5897083 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs113402462 | chr6:5897098-5897099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567164850 | chr6:5897112-5897113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs537907795 | chr6:5897119-5897120 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs79979994 | chr6:5897170-5897171 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs373288822 | chr6:5897188-5897189 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs577940487 | chr6:5897190-5897191 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545087223 | chr6:5897222-5897223 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554170153 | chr6:5897243-5897244 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572626677 | chr6:5897260-5897261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs77790689 | chr6:5897328-5897329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561429631 | chr6:5897349-5897350 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576715297 | chr6:5897427-5897428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370663745 | chr6:5897465-5897466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148520549 | chr6:5897529-5897530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs200583216 | chr6:5897545-5897546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs544298726 | chr6:5897584-5897585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs71540884 | chr6:5897635-5897636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs6929188 | chr6:5897649-5897650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs60760884 | chr6:5897653-5897654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs377085318 | chr6:5897693-5897694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369468054 | chr6:5897695-5897696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs150306646 | chr6:5897696-5897697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9504572 | chr6:5897697-5897698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs71312604 | chr6:5897699-5897700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs74207251 | chr6:5897705-5897706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs11243038 | chr6:5897768-5897769 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Developmental delay | 19490664 | CNVD |
Cancer | 21183584 | CNVD |
Multiple Epiphyseal Dysplasia | 20877625 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Glaucoma | 18694899 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
dysmorphism | 22105932 | CNVD |
psychomotor delay | 22105932 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:5892800-5897000 | Weak transcription | Fetal Brain Female | brain |
2 | chr6:5893000-5898400 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr6:5893200-5899000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr6:5896000-5898200 | Weak transcription | NHDF-Ad | bronchial |
5 | chr6:5896600-5897000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
6 | chr6:5897000-5897400 | Enhancers | Fetal Brain Female | brain |
7 | chr6:5897200-5897400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr6:5898200-5899800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr6:5898200-5900000 | Enhancers | NHDF-Ad | bronchial |
10 | chr6:5898400-5898600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr6:5898400-5899200 | Enhancers | Adipose Nuclei | Adipose |
12 | chr6:5898600-5898800 | Enhancers | Pancreas | Pancrea |
13 | chr6:5898600-5899400 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr6:5898800-5899000 | Weak transcription | Pancreas | Pancrea |
15 | chr6:5899000-5899200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
16 | chr6:5899200-5900600 | Weak transcription | Adipose Nuclei | Adipose |
17 | chr6:5899400-5899800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
18 | chr6:5899800-5905200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
19 | chr6:5899800-5905400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
20 | chr6:5900000-5904400 | Weak transcription | NHDF-Ad | bronchial |